Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1122

Introduced
2/7/25  

Caption

China Technology Transfer Control Act of 2025

Impact

If enacted, HB1122 would impose significant restrictions on the exportation of specific technologies and intellectual properties vital to the national security of the United States. The legislation mandates that the President take action within specified timelines to implement regulations and conduct assessments of the technologies in question. This could result in heightened scrutiny of U.S.-China transactions, particularly in sectors where sensitive technologies, like artificial intelligence and semiconductor production, align with military objectives or human rights concerns.

Summary

House Bill 1122, titled the 'China Technology Transfer Control Act of 2025,' seeks to regulate the export and transfer of certain technologies and intellectual property to the People's Republic of China (PRC) that are deemed crucial to the U.S. national interest. The bill defines 'covered national interest technology and intellectual property' as technology that could significantly enhance China's military capacity or facilitate human rights abuses. It establishes a framework for controlled exports of such technologies by the President and requires a report from relevant agencies assessing whether these technologies should be regulated under existing export laws.

Contention

The bill may lead to tensions in U.S.-China relations as it poses financial and operational challenges for tech firms that rely on the Chinese market. Critics may argue that over-regulation could stifle legitimate technological exchanges and collaborations with China, posing risks for innovation. There may be concerns from the business community about the broad definitions used in the bill, which could encompass a wide array of technologies and lead to unintended consequences for non-military related fields.

Congress_id

119-HR-1122

Introduced_date

2025-02-07

Additional_details

Moreover, the bill allows the President to impose sanctions on entities that engage with the PRC under specified conditions. This provision might invite further debate about its implementation and effectiveness in curbing China’s technological advancements that threaten U.S. interests. The legislative intent demonstrates a balance between safeguarding national security and maintaining a competitive edge in the global technology race.

Companion Bills

No companion bills found.

Similar Bills

US SB321

Decoupling America's Artificial Intelligence Capabilities from China Act of 2025

US HB1679

Global Investment in American Jobs Act of 2025

US SB672

Protect America’s Innovation and Economic Security from CCP Act of 2025

US HB1468

Protect America’s Innovation and Economic Security from CCP Act of 2025

US SB1235

Expanding Partnerships for Innovation and Competitiveness Act

US HB661

Maximizing Israel-U.S. Research Advancement and Collaborative Leadership in Emerging Medical Technology Act of 2025 or the MIRACLE Medical Technology Act of 2025This bill requires the Department of Health and Human Services (HHS) to implement a program for the United States and Israel to collaborate on developing and delivering health care products and services. The program must include coordinated activities in specified areas, including research and development, use of innovative technology, intellectual property protection, regulatory harmonization, disease prevention, and biological product manufacturing. The bill authorizes HHS to establish a joint United States-Israel Health Care Collaboration Center in the United States to leverage existing expertise for advancing the program’s purposes.

US HB1920

FARMLAND Act of 2025 Foreign Agricultural Restrictions to Maintain Local Agriculture and National Defense Act of 2025

US HB1229

United States-Israel Defense Partnership Act of 2025